Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
Terminated2
Suspended2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

terminated225%
completed450%
suspended225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8